Saichem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 23-12-2024
- Paid Up Capital ₹ 1.00 M
as on 23-12-2024
- Company Age 48 Year, 3 Months
- Last Filing with ROC 31 Mar 2012
- Satisfied Charges ₹ 0.51 M
as on 23-12-2024
About Saichem Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹0.51 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chuni Lal and Gurmesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24231HP1976PTC003684
- Company No.
003684
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 1976
- Date of AGM
29 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationHimachal Pradesh, Himachal Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saichem Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chuni Lal  | Managing Director | 15-May-1998 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurmesh Kumar | Director | 10-Jan-2008 | Current |
Financial Performance of Saichem Laboratories.
Enhance accessibility to Saichem Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Saichem Laboratories?
Unlock access to Saichem Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
White Rose Pharma Chem LimitedActive 25 years 2 monthsChuni Lal and Gurmesh Kumar are mutual person
- White Rose Estate And Investment Private LimitedActive 27 years 4 months
Chuni Lal and Gurmesh Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Jan 1989 | ₹0.40 M | Satisfied |
State Bank Of India Creation Date: 27 Feb 1983 | ₹0.11 M | Satisfied |
How Many Employees Work at Saichem Laboratories?
Unlock and access historical data on people associated with Saichem Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saichem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saichem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
